Page last updated: 2024-10-31

naphazoline and Di Guglielmo Disease

naphazoline has been researched along with Di Guglielmo Disease in 2 studies

Naphazoline: An adrenergic vasoconstrictor agent used as a decongestant.

Research Excerpts

ExcerptRelevanceReference
"Even though the erythroleukemia cell lines K562 and HEL do not express α1-adrenoceptors, some α1-adrenergic drugs influence both survival and differentiation of these cell lines."1.37α1-adrenergic drugs exhibit affinity to a thapsigargin-sensitive binding site and interfere with the intracellular Ca2+ homeostasis in human erythroleukemia cells. ( Fuchs, R; Haas, HS; Leitinger, G; Letofsky-Papst, I; Sadjak, A; Schauenstein, K; Schraml, E; Stelzer, I, 2011)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fuchs, R2
Schraml, E2
Leitinger, G2
Stelzer, I2
Allard, N1
Haas, HS2
Schauenstein, K2
Sadjak, A2
Letofsky-Papst, I1

Other Studies

2 other studies available for naphazoline and Di Guglielmo Disease

ArticleYear
α1-Adrenergic drugs modulate differentiation and cell death of human erythroleukemia cells through non adrenergic mechanism.
    Experimental cell research, 2011, Oct-01, Volume: 317, Issue:16

    Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Apopt

2011
α1-adrenergic drugs exhibit affinity to a thapsigargin-sensitive binding site and interfere with the intracellular Ca2+ homeostasis in human erythroleukemia cells.
    Experimental cell research, 2011, Dec-10, Volume: 317, Issue:20

    Topics: Adrenergic Agents; Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-1 Receptor Antagonists; Ag

2011